Hong Kong Hospital Authority Establishes New Office to Accelerate Introduction of Innovative Drugs and Medical Devices
The Hong Kong Hospital Authority (HA) announced on June 8 the formal establishment of the "Office for the Introduction of Innovative Drugs and Medical Devices." This initiative is in response to recommendations in the Chief Executive's Policy Address, aiming to provide patients with more advanced and high-quality treatment options through a more efficient mechanism.
This newly established office will play a key role. It will proactively contact global pharmaceutical companies and medical device suppliers to understand the latest medical technologies and products on the market. Through this unified communication window, the HA can more quickly evaluate which new drugs and equipment are suitable for introduction into Hong Kong's public hospital system, enhancing the competitiveness of medical services.
In the past, the procedure for introducing new drugs usually required multiple reviews, making the process relatively lengthy. Following the establishment of the new office, efforts will be made to simplify the relevant processes. This is good news for patients with rare or serious diseases, as they will have the opportunity to access new drugs with clinical evidence earlier, thereby improving treatment outcomes.
Furthermore, this plan aligns with the government's "1+" drug registration mechanism. This mechanism allows for the accelerated review of new drugs that have already been certified in other regions under specific conditions. This not only shortens the time for drugs to reach the market but also helps establish Hong Kong as an international medical innovation hub, attracting more advanced R&D institutions to develop in Hong Kong.
The Hospital Authority stated that it will continue to monitor global trends in medical technology development. By introducing more "good drugs" and "new drugs," the government hopes to further enhance the medical standards of public hospitals, ensuring that citizens can enjoy the health protection brought by technological progress and aligning the medical system with international standards.